Created at	Source	Raw Value	Validated value
April 6, 2021, 12:31 a.m.	usa	Incidence of adverse events after administration of IMP in the phase II/III;Percentage of patients requiring escalation of oxygen therapy in non-invasive and invasive methods in phase III	Incidence of adverse events after administration of IMP in the phase II/III;Percentage of patients requiring escalation of oxygen therapy in non-invasive and invasive methods in phase III